Literature DB >> 8617439

Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta.

A M Gressner1, B Polzar, B Lahme, H G Mannherz.   

Abstract

The induction of apoptosis of rat liver parenchymal cells (PC) by transforming growth factor beta (TGF-beta)-expressing transforming fat-storing cells (FSC), i.e., myofibroblasts (MFB), was studied under culture conditions and compared with the apoptotic effect of human recombinant TGF-beta1. MFB were obtained by subculture of FSC. The TGF-beta concentration in the conditioned medium of myofibroblast (MFBcM) determined with the Mink cell proliferation inhibition assay was <0.25 ng/mL/24 in the native medium, but 1.9 ng/mL24 h after transient acidification. MFBcM added in various dilutions and for different times to PC monolayers induced progressive cell detachment from the plastic support and increase of lactate dehydrogenase (LDH) activity in the medium. The reduction of mitochondrial dehydrogenase activity in PC (XTT or WST-1 test) was an early sign of MFBcM-induced functional impairment of PC. Short term exposure of PC with MFBcM for 3 hours was sufficient to induce the deleterious effects on PC, but neither native (nonactivated) MFBcM nor conditioned medium of untransformed FSC (FSCcM), in which TGF-beta was not detectable, were able to impair function and viability of PC. Activated MFBcM increased strongly (up to 21-fold) the concentration of oligonucleosomal DNA fragments both in the adherent and detached fraction of PC. Internucleosomal DNA fragments (DNA ladder) were demonstrated by electrophoresis of extracted DNA on agarose gels and by in situ end-labeling of DNA breaks (TUNEL reaction) only in MFBcM-exposed PC. MFBcM-treated PC exhibited intense fluorescence after staining with DNA-binding dye Hoechst 33342 and an increased number of cells with fragmented nuclei. All these criteria point to MFBcM-generated apoptosis of cultured PC, which were found to be very similar to those induced by human recombinant TGF-beta1. The exclusive role of active TGF-beta in MFBcM as mediator of the apoptotic effects of MFB was proven by preincubation of the conditioned medium with human recombinant latency-associated peptide, which reversed completely MFBcM induced reduction of the XTT-test and the MFBcM-generated increase of oligonucleosomal DNA fragments. Partial reversibility was reached by preincubation of the medium with recombinant soluble type II TGF-beta receptor. The data let us conclude that transformed FSC, i.e., MFB in damaged liver, could participate in the mechanisms of PC apoptosis by paracrine loops involving TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617439     DOI: 10.1002/hep.510230324

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.

Authors:  Stephen M Riordan; Roger Williams
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

Authors:  Wook-Hwan Kim; Kunio Matsumoto; Kazuhiko Bessho; Toshikazu Nakamura
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair.

Authors:  B Saile; T Knittel; N Matthes; P Schott; G Ramadori
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Effects of silymarin and pentoxifylline on matrix metalloproteinase-1 and -2 expression and apoptosis in experimental hepatic fibrosis.

Authors:  Eray Kara; Teoman Coşkun; Yavuz Kaya; Okan Yumuş; Seda Vatansever; Ahmet Var
Journal:  Curr Ther Res Clin Exp       Date:  2008-12

Review 5.  Reversal of liver cirrhosis: current evidence and expectations.

Authors:  Young Kul Jung; Hyung Joon Yim
Journal:  Korean J Intern Med       Date:  2017-02-08       Impact factor: 2.884

6.  Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis.

Authors:  Ting Liu; Shujia Chen; Xiaoli Xie; Hongqun Liu; Yongjuan Wang; Shengbin Qi; Linping Shi; Xue Zhou; Jiuna Zhang; Shuling Wang; Yijun Wang; Shengxiong Chen; Shiying Dou; Xiaoyu Jiang; Ruolin Cui; Huiqing Jiang
Journal:  J Cell Mol Med       Date:  2021-11-09       Impact factor: 5.310

7.  Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Comp Hepatol       Date:  2007-07-30

8.  Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor.

Authors:  Olav A Gressner; Birgit Lahme; Monika Siluschek; Katharina Rehbein; Jens Herrmann; Ralf Weiskirchen; Axel M Gressner
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.